No. 29-3, September 2017
Index
- A Message from the Editor
- Executive Summaries
- Improving the Health of Healthcare Companies
- Investor Protection and Governance in the Valuation of Emerging Markets Investments
- Issue Information ‐ TOC
- Statement of the Financial Economists Roundtable: Corporate Tax Reform
- The Empirical Average Cost of Capital: A New Approach to Estimating the Cost of Corporate Funds
- The Evolving Shareholder Activist Landscape (How Companies Can Prepare for It)
- The Keys to Success in Spinoffs
- Two Different Ways of Treating Corporate Cash in FCF Valuations—and the Importance of Getting the Cost of Capital Right
- University of Texas Roundtable on The Role of Private Equity in the Financing and Restructuring of Oil and Gas Companies
- University of Texas Roundtable on The State of the U.S. Private Equity Market
- Valuation of a Pharmaceutical Licensing Contract